Page last updated: 2024-10-29

ipriflavone and Alloxan Diabetes

ipriflavone has been researched along with Alloxan Diabetes in 3 studies

ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.

Research Excerpts

ExcerptRelevanceReference
"Ipriflavone was reported to be primarily metabolized via hepatic cytochrome P450 (CYP) 1A1/2 and 2C11 in male Sprague-Dawley rats."1.35Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin. ( Choi, YH; Chung, HJ; Kim, SH; Lee, DY; Lee, I; Lee, MG; Lee, U, 2009)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Nie, R1
Lu, J1
Xu, R1
Yang, J1
Shen, X2
Ouyang, X1
Zhu, D1
Huang, Y1
Zhao, T1
Zhao, X1
Lu, Y1
Qian, M1
Wang, J1
Lee, DY1
Chung, HJ1
Choi, YH1
Lee, U1
Kim, SH1
Lee, I1
Lee, MG1
Shino, A1
Tsukuda, R1
Odaka, H1
Kitazaki, T1
Tsuda, M1
Matsuo, T1

Other Studies

3 other studies available for ipriflavone and Alloxan Diabetes

ArticleYear
Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice.
    Aging cell, 2022, Volume: 21, Issue:3

    Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Humans; Isoflavones; Mice; Phosphat

2022
Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2009, Dec-08, Volume: 38, Issue:5

    Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Injections,

2009
Suppressive effect of ipriflavone on bone depletion in the experimental diabetic rat: dose response of ipriflavone.
    Life sciences, 1988, Volume: 42, Issue:11

    Topics: Animals; Body Weight; Bone Resorption; Diabetes Mellitus, Experimental; Dose-Response Relationship,

1988